Skip to main content
Screener/Healthcare/Biotechnology

PLX — Protalix BioTherapeutics, Inc.

AMEX
$2.20-0.03 (-1.13%)
Micro CapPenny StockUnder $5Healthcare
$1.32
$3.19
$2.18
$2.24
EPS (TTM)$-0.08
P/E Ratio—
Dividend Yield—
Market Cap$230.8M
Volume442K
Prev Close$2.22
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$9.1M-$5.5M$-0.0749.4%-60.3%
Q3 '25$17.9M$2.4M$0.0353.4%13.2%
Q2 '25$15.7M$164K$0.0062.5%1.0%
Q1 '25$10.1M-$3.6M$-0.0519.1%-35.8%
Q4 '24$18.2M$6.5M$0.0978.7%35.6%
Q3 '24$18.0M$3.2M$0.0353.4%18.0%
Q2 '24$13.5M-$2.2M$-0.0329.8%-16.4%
Q1 '24$3.7M-$4.6M$-0.0630.6%-122.6%
Get Your Daily Market Recap